Item Qty Item Total
Your cart is empty.
*Subtotal does not include tax, promos or shipping
SUBTOTAL: $0.00
Login 
Attn: If you received Historical Order Emails - please disregard these were sent in error

2/25/2015 - New York Attorney General Investigation Letter

On February 23, 2015, Nature’s Way received a letter which constituted “a request for documents and information relating to an ongoing investigation by the New York State Office of the Attorney General (“NYAG”) concerning the authenticity and purity of herbal dietary supplements and associated marketing.” The letter from the NYAG makes no allegations against Nature’s Way and provides no indications of any quality or compliance problem with any Nature’s Way product. The letter is simply a “request” for documents and information.

Nature’s Way products are produced in accordance with the federal Food and Drug Administration’s (FDA’s) Dietary Supplement Good Manufacturing Practices (GMPs), 21 CFR 111. Nature’s Way is audited by FDA to confirm compliance and continues to hold Dietary Supplement GMP Certification through NSF International, a GMP Certificate from the Australian Department of Health’s Therapeutic Goods Association (TGA) and is a licensed site for the production of Natural Health Products (NHPs) marketed in Canada. Nature’s Way intends to cooperate with the NYAG request for documents and information, as we are proud of our Quality Assurance processes and the steps that we take to both comply with the law and produce products of the highest quality.


Read More...

For Immediate Release:

Sale of Enzymatic Therapy, Inc. to Nature’s Way Holding Company Finalized

Nature’s Way Holding Company names Randy J. Rose President/CEO and Rory Mahony Chief Operating Officer of new natural medicine powerhouse.

GREEN BAY, WI —11/10/2008—Representatives of the Dr. Willmar Schwabe Group, of Karlsruhe, Germany, have confirmed that corporate ownership for Enzymatic Therapy, Inc., of Green Bay, Wisconsin, was transferred on Friday, October 31, 2008.

A shareholder group comprised of North Castle Partners, LLC, and members of Enzymatic Therapy Management previously owned Enzymatic Therapy, Inc.

Details of the sale price are unavailable, as is information regarding the combined revenue of the entities.

The North American operating platform for the Schwabe group will be named Nature's Way Holding Company, and will include the entire operations of Enzymatic Therapy, Inc. and Nature’s Way Products Inc.

The combined group will create an organization with great depth of technical and scientific expertise that will market a very broad line of wellness products and natural medicines.

Nature’s Way Holding Company will continue to bring trusted consumer solutions forward under highly popular brand names that include Nature's WayTM, AliveTM, ZucolTM, UmckaTM, Pearls TM Whole Body CleanseTM, RemifeminR, and Enzymatic TherapyR.

Additionally, the company will continue to market professional products sold only through medical professionals under labels that include Integrative TherapeuticsR.

Nature’s Way Holding Company has confirmed to its customers that all merchandising and marketing programs previously announced for both product lines will continue. The Company also will continue to distribute products to over 40 countries outside the United States.

Randy J. Rose, formerly the President and CEO of Enzymatic Therapy, has been named the President and CEO of the combined business, and Rory Mahony, who previously served as COO & General Manager of Nature's Way, will be the Chief Operating Officer. Both Mr. Rose and Mr. Mahony will join the Board of Directors for the new corporate entity.

Nature’s Way Holding Company operates manufacturing and distribution facilities in Utah and Wisconsin, and has offices across the United States, including those in New York City, St Louis, Missouri, Green Bay, Wisconsin, and in Springville, Utah. It also has a marketing and distribution company in Canada.

Consumer enthusiasm for the Enzymatic and Nature's Way products has resulted in strong and steady growth of the brands. Going forward, the company will focus on further acceleration of these very positive growth rates by continuing to deliver quality products that meet customer needs.
 
[x]
 
[x]
 
[x]